| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.903 | 0.001 | 0.903 | Calcium antagonist | 0.694 0.001 CID_173322 0.538 0.002 CID_91992444 0.833 0.001 CID_154699654 | ||
| 0.898 | 0.002 | 0.898 | Calcium channel blocker | 0.731 0.003 CID_173322 0.754 0.003 CID_91992444 0.797 0.003 CID_154699654 | ||
| 0.849 | 0.003 | 0.853 | Vasodilator, coronary | 0.821 0.004 CID_173322 0.459 0.022 CID_91992444 0.853 0.003 CID_154699654 | CID_154699654 | |
| 0.813 | 0.004 | 0.829 | Vasodilator, peripheral | 0.829 0.003 CID_173322 0.576 0.018 CID_91992444 0.824 0.004 CID_154699654 | CID_173322 | |
| 0.758 | 0.003 | 0.758 | Calcium channel (voltage-sensitive) blocker | 0.537 0.004 CID_173322 0.526 0.004 CID_91992444 0.481 0.004 CID_154699654 | ||
| 0.73 | 0.001 | 0.73 | Calcium channel L-type blocker | 0.673 0.002 CID_173322 0.513 0.002 CID_91992444 0.61 0.002 CID_154699654 | ||
| 0.663 | 0.003 | 0.717 | Calcium channel L-type activator | 0.717 0.002 CID_173322 0.657 0.004 CID_91992444 0.684 0.003 CID_154699654 | CID_173322 | |
| 0.632 | 0.005 | 0.691 | Vasodilator | 0.691 0.004 CID_173322 0.366 0.029 CID_91992444 0.671 0.005 CID_154699654 | CID_173322 | |
| 0.59 | 0.003 | 0.673 | Calcium channel activator | 0.673 0.002 CID_173322 0.504 0.005 CID_91992444 0.659 0.002 CID_154699654 | CID_173322 | |
| 0.489 | 0.024 | 0.499 | Spasmolytic | 0.214 0.109 CID_173322 0.205 0.115 CID_91992444 0.499 0.023 CID_154699654 | CID_154699654 | |
| 0.457 | 0.02 | 0.494 | Cardiotonic | 0.494 0.016 CID_173322 0.245 0.086 CID_91992444 0.478 0.018 CID_154699654 | CID_173322 | |
| 0.347 | 0.004 | 0.593 | TRPA1 agonist | 0.593 0.003 CID_173322 0.127 0.051 CID_91992444 0.237 0.006 CID_154699654 | CID_173322 | |
| 0.345 | 0.022 | 0.345 | P-glycoprotein inhibitor | 0.211 0.058 CID_173322 0.297 0.029 CID_91992444 0.339 0.023 CID_154699654 | ||
| 0.328 | 0.032 | 0.448 | Cyclic AMP phosphodiesterase inhibitor | 0.448 0.011 CID_173322 0.164 0.13 CID_91992444 0.378 0.02 CID_154699654 | CID_173322 | |
| 0.291 | 0.036 | 0.291 | 5 Hydroxytryptamine 1E antagonist | 0.284 0.041 CID_173322 0.215 0.114 CID_91992444 0.265 0.058 CID_154699654 | ||
| 0.239 | 0.01 | 0.308 | Neuropeptide Y1 antagonist | 0.308 0.005 CID_173322 0.192 0.022 CID_91992444 0.239 0.01 CID_154699654 | CID_173322 | |
| 0.31 | 0.082 | 0.356 | Antithrombotic | 0.356 0.062 CID_173322 0.32 0.077 CID_154699654 | CID_173322 | |
| 0.232 | 0.011 | 0.41 | Adenylate kinase inhibitor | 0.41 0.003 CID_173322 0.109 0.054 CID_91992444 0.248 0.01 CID_154699654 | CID_173322 | |
| 0.228 | 0.013 | 0.228 | Alpha 2c adrenoreceptor antagonist | 0.178 0.023 CID_173322 0.135 0.04 CID_91992444 0.16 0.028 CID_154699654 | ||
| 0.245 | 0.05 | 0.263 | Sigma receptor agonist | 0.205 0.06 CID_173322 0.263 0.046 CID_91992444 | CID_91992444 | |
| 0.243 | 0.055 | 0.298 | Platelet aggregation inhibitor | 0.298 0.036 CID_173322 0.28 0.041 CID_154699654 | CID_173322 | |
| 0.207 | 0.022 | 0.236 | Alpha 2b adrenoreceptor antagonist | 0.236 0.017 CID_173322 0.11 0.066 CID_91992444 0.235 0.017 CID_154699654 | CID_173322 | |
| 0.225 | 0.085 | 0.291 | Platelet antagonist | 0.285 0.058 CID_173322 0.291 0.056 CID_154699654 | CID_154699654 | |
| 0.203 | 0.078 | 0.26 | Psychostimulant | 0.153 0.113 CID_173322 0.26 0.055 CID_154699654 | CID_154699654 | |
| 0.138 | 0.024 | 0.138 | Alpha 1b adrenoreceptor antagonist | 0.129 0.027 CID_173322 0.096 0.037 CID_154699654 | ||
| 0.11 | 0.013 | 0.11 | Calcium channel T-type blocker | |||
| 0.154 | 0.07 | 0.289 | CF transmembrane conductance regulator agonist | 0.289 0.004 CID_173322 0.206 0.019 CID_154699654 | CID_173322 | |
| 0.088 | 0.01 | 0.128 | Nicotinic alpha3beta2 receptor antagonist | 0.06 0.027 CID_173322 0.078 0.014 CID_91992444 0.128 0.004 CID_154699654 | CID_154699654 | |
| 0.141 | 0.064 | 0.186 | Farnesoid X receptor antagonist | 0.186 0.027 CID_173322 0.144 0.059 CID_154699654 | CID_173322 | |
| 0.102 | 0.03 | 0.137 | Glycine receptor antagonist | 0.137 0.011 CID_173322 0.13 0.013 CID_154699654 | CID_173322 | |
| 0.073 | 0.013 | 0.176 | Aldosterone antagonist | 0.176 0.004 CID_173322 0.108 0.008 CID_154699654 | CID_173322 | |
| 0.129 | 0.07 | 0.14 | Acetylcholinesterase inhibitor | 0.14 0.062 CID_91992444 | CID_91992444 | |
| 0.075 | 0.019 | 0.104 | Dopamine transporter inhibitor | 0.045 0.037 CID_91992444 0.104 0.011 CID_154699654 | CID_154699654 | |
| 0.068 | 0.015 | 0.133 | Mineralocorticoid receptor antagonist | 0.133 0.005 CID_173322 0.08 0.011 CID_154699654 | CID_173322 | |
| 0.091 | 0.04 | 0.091 | Alpha 1a adrenoreceptor antagonist | |||
| 0.118 | 0.068 | 0.368 | Anesthetic local | 0.368 0.008 CID_91992444 0.108 0.076 CID_154699654 | CID_91992444 | |
| 0.117 | 0.07 | 0.154 | Acetylcholine muscarinic antagonist | 0.154 0.041 CID_91992444 | CID_91992444 | |
| 0.135 | 0.09 | 0.136 | Cholinergic | 0.136 0.09 CID_91992444 | CID_91992444 | |
| 0.15 | 0.105 | 0.249 | Lipocortins synthesis antagonist | 0.249 0.034 CID_173322 0.17 0.08 CID_154699654 | CID_173322 | |
| 0.086 | 0.044 | 0.115 | Nicotinic alpha4beta2 receptor antagonist | 0.115 0.02 CID_154699654 | CID_154699654 | |
| 0.071 | 0.03 | 0.101 | Dopamine uptake inhibitor | 0.101 0.018 CID_154699654 | CID_154699654 | |
| 0.073 | 0.034 | 0.118 | Alpha 1d adrenoreceptor antagonist | 0.118 0.019 CID_173322 0.054 0.046 CID_154699654 | CID_173322 | |
| 0.101 | 0.067 | 0.121 | Toll-Like receptor 4 antagonist | 0.121 0.043 CID_173322 0.107 0.059 CID_91992444 0.117 0.047 CID_154699654 | CID_173322 | |
| 0.129 | 0.096 | 0.156 | Acetylcholine M1 receptor antagonist | 0.156 0.069 CID_91992444 | CID_91992444 | |
| 0.111 | 0.079 | 0.147 | Acetylcholine antagonist | 0.147 0.051 CID_91992444 0.102 0.09 CID_154699654 | CID_91992444 | |
| 0.113 | 0.081 | 0.151 | Cholinergic antagonist | 0.151 0.052 CID_91992444 0.102 0.092 CID_154699654 | CID_91992444 | |
| 0.048 | 0.018 | 0.052 | Acid-sensing ion channel blocker | 0.052 0.015 CID_91992444 | CID_91992444 | |
| 0.076 | 0.047 | 0.076 | Histone deacetylase SIRT1 stimulant | 0.074 0.05 CID_173322 | ||
| 0.076 | 0.047 | 0.076 | Histone deacetylase stimulant | 0.074 0.05 CID_173322 | ||
| 0.067 | 0.038 | 0.077 | Nitric oxide donor | 0.077 0.025 CID_173322 0.073 0.029 CID_154699654 | CID_173322 | |
| 0.247 | 0.218 | 0.296 | Apoptosis agonist | 0.296 0.175 CID_91992444 0.244 0.221 CID_154699654 | CID_91992444 | |
| 0.143 | 0.117 | 0.185 | Hepatoprotectant | 0.185 0.075 CID_173322 0.149 0.11 CID_154699654 | CID_173322 | |
| 0.079 | 0.053 | 0.079 | Alpha 1 adrenoreceptor antagonist | |||
| 0.076 | 0.052 | 0.098 | Alpha 2a adrenoreceptor antagonist | 0.076 0.052 CID_173322 0.098 0.037 CID_154699654 | CID_154699654 | |
| 0.087 | 0.066 | 0.087 | Alpha adrenoreceptor antagonist | |||
| 0.083 | 0.062 | 0.195 | Androgen antagonist | 0.195 0.014 CID_173322 0.109 0.04 CID_154699654 | CID_173322 | |
| 0.06 | 0.042 | 0.116 | Potassium channel intermediate-conductance Ca-activated blocker | 0.116 0.005 CID_173322 | CID_173322 | |
| 0.057 | 0.048 | 0.084 | Acetylcholine M2 receptor antagonist | 0.084 0.027 CID_91992444 | CID_91992444 | |
| 0.08 | 0.071 | 0.082 | Antiadrenergic | 0.082 0.069 CID_173322 | CID_173322 | |
| 0.181 | 0.177 | 0.287 | Hypoxia-inducible factor 1 alpha inhibitor | 0.287 0.072 CID_173322 | CID_173322 | |
| 0.076 | 0.072 | 0.08 | Adrenaline antagonist | 0.08 0.068 CID_173322 | CID_173322 | |
| 0.031 | 0.029 | 0.043 | Transforming growth factor beta 2 antagonist | 0.043 0.01 CID_173322 0.036 0.018 CID_154699654 | CID_173322 | |
| 0.06 | 0.058 | 0.093 | Calcium channel P-type blocker | 0.093 0.008 CID_91992444 | CID_91992444 | |
| 0.122 | 0.122 | 0.14 | Pregnane X receptor agonist | 0.14 0.074 CID_173322 | CID_173322 | |
| 0.031 | 0.032 | 0.036 | Protein kinase C beta I inhibitor | 0.036 0.017 CID_154699654 | CID_154699654 | |
| 0.117 | 0.12 | 0.161 | NOS3 expression enhancer | 0.161 0.062 CID_173322 | CID_173322 | |
| 0.037 | 0.042 | 0.046 | Nicotinic receptor alpha3 subunit antagonist | 0.046 0.028 CID_154699654 | CID_154699654 | |
| 0.208 | 0.215 | 0.313 | Alpha-glucosidase inhibitor | 0.313 0.153 CID_173322 0.283 0.169 CID_91992444 | CID_173322 | |
| 0.077 | 0.086 | 0.154 | Breast cancer-resistant protein inhibitor | 0.094 0.062 CID_173322 0.154 0.022 CID_91992444 | CID_91992444 | |
| 0.103 | 0.113 | 0.146 | Interleukin 4 antagonist | 0.136 0.064 CID_173322 0.146 0.054 CID_91992444 | CID_91992444 | |
| 0.125 | 0.138 | 0.247 | Platelet adhesion inhibitor | 0.247 0.05 CID_91992444 | CID_91992444 | |
| 0.047 | 0.06 | 0.063 | Acetylcholine M3 receptor antagonist | 0.063 0.038 CID_91992444 | CID_91992444 | |
| 0.134 | 0.148 | 0.147 | Death-associated protein kinase 2 inhibitor | 0.147 0.114 CID_173322 | CID_173322 | |
| 0.042 | 0.059 | 0.077 | Protein kinase C eta inhibitor | 0.05 0.044 CID_91992444 0.077 0.025 CID_154699654 | CID_154699654 | |
| 0.027 | 0.045 | 0.032 | ADAM10 endopeptidase inhibitor | 0.032 0.027 CID_154699654 | CID_154699654 | |
| 0.052 | 0.071 | 0.082 | Bcl2 antagonist | 0.082 0.03 CID_91992444 | CID_91992444 | |
| 0.044 | 0.072 | 0.088 | Adrenaline uptake inhibitor | 0.088 0.023 CID_154699654 | CID_154699654 | |
| 0.039 | 0.068 | 0.063 | Nicotinic receptor alpha4 subunit antagonist | 0.063 0.02 CID_154699654 | CID_154699654 | |
| 0.024 | 0.057 | 0.032 | Protein kinase C beta II inhibitor | 0.032 0.023 CID_154699654 | CID_154699654 | |
| 0.076 | 0.11 | 0.131 | Bile acid receptor antagonist | 0.131 0.013 CID_173322 0.092 0.068 CID_154699654 | CID_173322 | |
| 0.132 | 0.173 | 0.201 | Free radical scavenger | 0.201 0.097 CID_173322 | CID_173322 | |
| 0.02 | 0.062 | 0.03 | Catechol O-methyltransferase inhibitor | 0.03 0.027 CID_173322 | CID_173322 | |
| 0.016 | 0.059 | 0.054 | NMDA 2D receptor antagonist | 0.054 0.006 CID_173322 | CID_173322 | |
| 0.055 | 0.099 | 0.096 | Acetylcholine nicotinic antagonist | 0.096 0.042 CID_154699654 | CID_154699654 | |
| 0.024 | 0.076 | 0.117 | Phosphorylase inhibitor | 0.117 0.01 CID_173322 | CID_173322 | |
| 0.077 | 0.13 | 0.102 | Multidrug resistance-associated protein 1 inhibitor | 0.1 0.078 CID_173322 0.102 0.074 CID_91992444 | CID_91992444 | |
| 0.027 | 0.083 | 0.048 | Phenylethanolamine N methyltransferase inhibitor | 0.048 0.016 CID_154699654 | CID_154699654 | |
| 0.13 | 0.192 | 0.186 | Antioxidant | 0.186 0.126 CID_173322 | CID_173322 | |
| 0.02 | 0.083 | 0.032 | Purinergic P2Y2 antagonist | 0.032 0.026 CID_173322 | CID_173322 | |
| 0.059 | 0.124 | 0.124 | Mediator release inhibitor | 0.124 0.044 CID_173322 | CID_173322 | |
| 0.105 | 0.17 | 0.167 | Amyloid beta precursor protein antagonist | 0.167 0.084 CID_173322 | CID_173322 | |
| 0.093 | 0.16 | 0.184 | Phospholipase A2 inhibitor | 0.184 0.052 CID_173322 | CID_173322 | |
| 0.071 | 0.138 | 0.129 | Beta glucuronidase inhibitor | 0.129 0.038 CID_173322 0.097 0.075 CID_154699654 | CID_173322 | |
| 0.045 | 0.114 | 0.059 | Ryanodine receptor antagonist | 0.059 0.041 CID_154699654 | CID_154699654 | |
| 0.056 | 0.127 | 0.086 | Neuropeptide Y antagonist | 0.086 0.051 CID_173322 | CID_173322 | |
| 0.064 | 0.135 | 0.081 | Thioredoxin inhibitor | 0.081 0.08 CID_173322 | CID_173322 | |
| 0.12 | 0.198 | 0.199 | Catenin beta inhibitor | 0.157 0.09 CID_173322 0.199 0.033 CID_154699654 | CID_154699654 | |
| 0.062 | 0.144 | 0.087 | Thioredoxin reductase inhibitor | 0.087 0.047 CID_173322 | CID_173322 | |
| 0.024 | 0.106 | 0.063 | Glutamate (mGluR1) antagonist | 0.063 0.036 CID_173322 | CID_173322 | |
| 0.035 | 0.117 | 0.066 | Neuronal nicotinic receptor antagonist | 0.066 0.049 CID_154699654 | CID_154699654 | |
| 0.037 | 0.123 | 0.079 | DNA gyrase inhibitor | 0.079 0.027 CID_173322 | CID_173322 | |
| 0.146 | 0.232 | 0.352 | Transcription factor NF kappa B inhibitor | 0.352 0.076 CID_173322 0.223 0.148 CID_154699654 | CID_173322 | |
| 0.051 | 0.143 | 0.088 | Viral attachment inhibitor | 0.088 0.035 CID_91992444 | CID_91992444 | |
| 0.014 | 0.108 | 0.03 | Epoxide hydrolase 1 inhibitor | 0.03 0.024 CID_173322 | CID_173322 | |
| 0.023 | 0.118 | 0.054 | 5 Hydroxytryptamine uptake inhibitor | 0.054 0.052 CID_154699654 | CID_154699654 | |
| 0.159 | 0.254 | 0.244 | Apoptosis antagonist | 0.244 0.134 CID_173322 | CID_173322 | |
| 0.076 | 0.174 | 0.129 | Toll-Like receptor antagonist | 0.129 0.073 CID_91992444 | CID_91992444 | |
| 0.136 | 0.238 | 0.276 | Thioredoxin glutathione reductase inhibitor | 0.276 0.117 CID_173322 | CID_173322 | |
| 0.032 | 0.136 | 0.091 | Thromboxane synthase inhibitor | 0.091 0.008 CID_173322 | CID_173322 | |
| 0.1 | 0.208 | 0.169 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.169 0.043 CID_173322 | CID_173322 | |
| 0.101 | 0.212 | 0.257 | Non-steroidal antiinflammatory agent | 0.257 0.04 CID_173322 | CID_173322 | |
| 0.05 | 0.164 | 0.075 | MDM2 inhibitor | 0.075 0.027 CID_173322 | CID_173322 | |
| 0.008 | 0.122 | 0.064 | Progesterone antagonist | 0.064 0.013 CID_173322 | CID_173322 | |
| 0.059 | 0.175 | 0.101 | Amylase inhibitor | 0.101 0.095 CID_173322 | CID_173322 | |
| 0.027 | 0.144 | 0.062 | Potassium channel (ATP-sensitive) activator | 0.062 0.015 CID_173322 | CID_173322 | |
| 0.028 | 0.147 | 0.065 | Potassium channel (Inward rectifier) activator | 0.065 0.015 CID_173322 | CID_173322 | |
| 0.056 | 0.181 | 0.103 | ABCA1 expression enhancer | 0.103 0.046 CID_173322 | CID_173322 | |
| 0.016 | 0.144 | 0.075 | Thromboxane A2 antagonist | 0.075 0.018 CID_173322 | CID_173322 | |
| 0.055 | 0.183 | 0.093 | Interleukin 5 antagonist | 0.093 0.05 CID_173322 | CID_173322 | |
| 0.041 | 0.169 | 0.086 | Adenosine A3 receptor antagonist | 0.086 0.036 CID_173322 | CID_173322 | |
| 0.084 | 0.214 | 0.214 | Anesthetic general | 0.214 0.067 CID_173322 | CID_173322 | |
| 0.019 | 0.15 | 0.082 | Thromboxane antagonist | 0.082 0.019 CID_173322 | CID_173322 | |
| 0.145 | 0.278 | 0.271 | Sodium/bile acid cotransporter inhibitor | 0.271 0.106 CID_173322 | CID_173322 | |
| 0.129 | 0.263 | 0.191 | Peptidyltransferase inhibitor | 0.191 0.111 CID_173322 | CID_173322 | |
| 0.143 | 0.279 | 0.412 | DNA polymerase beta inhibitor | 0.412 0.114 CID_173322 | CID_173322 | |
| 0.041 | 0.191 | 0.108 | Potassium channel activator | 0.108 0.041 CID_173322 | CID_173322 | |
| 0.03 | 0.18 | 0.093 | Beta adrenoreceptor antagonist | 0.093 0.019 CID_173322 0.061 0.054 CID_154699654 | CID_173322 | |
| 0.073 | 0.227 | 0.136 | Sphingosine 1-phosphate receptor 4 antagonist | 0.136 0.048 CID_173322 | CID_173322 | |
| 0.051 | 0.209 | 0.146 | Alkylator | 0.146 0.049 CID_173322 | CID_173322 | |
| 0.059 | 0.217 | 0.153 | Cytidine deaminase inhibitor | 0.153 0.073 CID_173322 0.121 0.099 CID_91992444 | CID_173322 | |
| 0.067 | 0.241 | 0.273 | Diuretic | 0.273 0.027 CID_173322 | CID_173322 | |
| 0.012 | 0.188 | 0.032 | Angiotensin II receptor antagonist | 0.032 0.028 CID_91992444 | CID_91992444 | |
| 0.013 | 0.192 | 0.066 | NMDA 2C receptor antagonist | 0.066 0.037 CID_173322 | CID_173322 | |
| 0.11 | 0.297 | 0.226 | Gastrin inhibitor | 0.226 0.11 CID_173322 | CID_173322 | |
| 0.058 | 0.246 | 0.189 | Mcl-1 antagonist | 0.189 0.062 CID_173322 | CID_173322 | |
| 0.04 | 0.228 | 0.117 | HIV-1 integrase (Overall Integration) inhibitor | 0.117 0.041 CID_173322 | CID_173322 | |
| 0.12 | 0.312 | 0.372 | DNA directed DNA polymerase inhibitor | 0.372 0.128 CID_173322 | CID_173322 | |
| 0.018 | 0.215 | 0.071 | Beta 1 adrenoreceptor antagonist | 0.071 0.025 CID_173322 | CID_173322 | |
| 0.018 | 0.215 | 0.066 | Glutamate (mGluR8) agonist | 0.066 0.005 CID_173322 | CID_173322 | |
| 0.194 | 0.395 | 0.319 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.319 0.188 CID_173322 | CID_173322 | |
| 0.067 | 0.284 | 0.164 | Interleukin agonist | 0.164 0.154 CID_173322 | CID_173322 | |
| 0.028 | 0.247 | 0.11 | Potassium channel (Ca-activated) activator | 0.11 0.048 CID_173322 | CID_173322 | |
| 0.048 | 0.271 | 0.131 | Protein-tyrosine phosphatase inhibitor | 0.131 0.1 CID_173322 | CID_173322 | |
| 0.013 | 0.236 | 0.038 | Retinoic acid alpha receptor agonist | 0.038 0.028 CID_173322 | CID_173322 | |
| 0.127 | 0.367 | 0.208 | Interleukin 2 agonist | 0.208 0.176 CID_173322 | CID_173322 | |
| 0.039 | 0.279 | 0.089 | GABA B receptor agonist | 0.089 0.028 CID_173322 | CID_173322 | |
| 0.074 | 0.319 | 0.163 | Interferon gamma antagonist | 0.163 0.063 CID_173322 | CID_173322 | |
| 0.06 | 0.315 | 0.142 | DNA methyltransferase I inhibitor | 0.142 0.112 CID_173322 | CID_173322 | |
| 0.094 | 0.35 | 0.324 | Cholesterol antagonist | 0.324 0.077 CID_173322 | CID_173322 | |
| 0.029 | 0.29 | 0.058 | Adenine nucleotide translocase inhibitor | 0.058 0.033 CID_173322 | CID_173322 | |
| 0.02 | 0.281 | 0.087 | Glutamate (mGluR group III) antagonist | 0.087 0.006 CID_173322 | CID_173322 | |
| 0.046 | 0.313 | 0.123 | Photosensitizer | 0.123 0.053 CID_173322 | CID_173322 | |
| 0.006 | 0.279 | 0.034 | NMDA receptor subunit 3A antagonist | 0.034 0.031 CID_173322 | CID_173322 | |
| 0.098 | 0.371 | 0.225 | RNA-directed DNA polymerase inhibitor | 0.225 0.069 CID_173322 | CID_173322 | |
| 0.023 | 0.3 | 0.058 | Purinergic P2X1 antagonist | 0.058 0.046 CID_173322 | CID_173322 | |
| 0.004 | 0.287 | 0.051 | Kainate receptor antagonist | 0.051 0.02 CID_173322 | CID_173322 | |
| 0.022 | 0.307 | 0.118 | M18 aspartyl aminopeptidase inhibitor | 0.118 0.072 CID_173322 | CID_173322 | |
| 0.031 | 0.317 | 0.08 | Glutamate (mGluR6) antagonist | 0.08 0.024 CID_173322 | CID_173322 | |
| 0.016 | 0.304 | 0.191 | Histidine decarboxylase inhibitor | 0.191 0.014 CID_173322 | CID_173322 | |
| 0.009 | 0.3 | 0.044 | NMDA receptor subunit 3B antagonist | 0.044 0.03 CID_173322 | CID_173322 | |
| 0.016 | 0.309 | 0.078 | NMDA receptor antagonist | 0.078 0.068 CID_173322 | CID_173322 | |
| 0.003 | 0.297 | 0.042 | NMDA receptor glycine site antagonist | 0.042 0.008 CID_173322 | CID_173322 | |
| 0.035 | 0.33 | 0.157 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.157 0.024 CID_173322 | CID_173322 | |
| 0.099 | 0.396 | 0.149 | Heat shock protein 70 antagonist | 0.149 0.048 CID_173322 | CID_173322 | |
| 0.013 | 0.322 | 0.045 | AICAR transformylase inhibitor | 0.045 0.029 CID_173322 | CID_173322 | |
| 0.04 | 0.356 | 0.163 | DOPA decarboxylase inhibitor | 0.163 0.015 CID_173322 | CID_173322 | |
| 0.071 | 0.39 | 0.133 | Sphingosine 1-phosphate receptor 5 antagonist | 0.133 0.093 CID_173322 | CID_173322 | |
| 0.009 | 0.328 | 0.041 | Nerve growth factor antagonist | 0.041 0.034 CID_173322 | CID_173322 | |
| 0.017 | 0.341 | 0.072 | Glutamate (mGluR4) antagonist | 0.072 0.01 CID_173322 | CID_173322 | |
| 0.011 | 0.339 | 0.102 | Biliverdin reductase inhibitor | 0.102 0.018 CID_173322 | CID_173322 | |
| 0.02 | 0.352 | 0.146 | M17 leucyl aminopeptidase inhibitor | 0.146 0.058 CID_173322 | CID_173322 | |
| 0.033 | 0.38 | 0.116 | Cathepsin H inhibitor | 0.116 0.08 CID_173322 | CID_173322 | |
| 0.078 | 0.428 | 0.286 | Transcription factor inhibitor | 0.286 0.163 CID_173322 | CID_173322 | |
| 0.065 | 0.425 | 0.264 | Transcription factor STAT3 inhibitor | 0.264 0.073 CID_173322 | CID_173322 | |
| 0.021 | 0.383 | 0.063 | CD45 antagonist | 0.063 0.019 CID_173322 | CID_173322 | |
| 0.014 | 0.379 | 0.038 | Kainate receptor agonist | 0.038 0.037 CID_173322 | CID_173322 | |
| 0.08 | 0.448 | 0.32 | Antibacterial | 0.32 0.12 CID_173322 | CID_173322 | |
| 0.035 | 0.404 | 0.138 | Dual specificity phosphatase inhibitor | 0.138 0.109 CID_173322 | CID_173322 | |
| 0.024 | 0.394 | 0.13 | UDP-glucose 4-epimerase inhibitor | 0.13 0.037 CID_173322 | CID_173322 | |
| 0.025 | 0.395 | 0.092 | Glutathione S-transferase inhibitor | 0.092 0.045 CID_173322 | CID_173322 | |
| 0.003 | 0.391 | 0.035 | Kynurenine 3 monooxygenase inhibitor | 0.035 0.012 CID_173322 | CID_173322 | |
| 0.028 | 0.417 | 0.141 | Xanthine oxidase inhibitor | 0.141 0.038 CID_173322 | CID_173322 | |
| 0.111 | 0.511 | 0.307 | Caspase 9 stimulant | 0.307 0.186 CID_173322 | CID_173322 | |
| 0.031 | 0.431 | 0.15 | Dual specificity phosphatase 3 inhibitor | 0.15 0.096 CID_173322 | CID_173322 | |
| 0.066 | 0.474 | 0.199 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.199 0.073 CID_173322 | CID_173322 | |
| 0.027 | 0.435 | 0.12 | Triose-phosphate isomerase inhibitor | 0.12 0.032 CID_173322 | CID_173322 | |
| 0.015 | 0.425 | 0.105 | GABA aminotransferase inhibitor | 0.105 0.024 CID_173322 | CID_173322 | |
| 0.03 | 0.448 | 0.2 | Mannose-6-phosphate isomerase inhibitor | 0.2 0.031 CID_173322 | CID_173322 | |
| 0.056 | 0.474 | 0.234 | 15-Lipoxygenase inhibitor | 0.234 0.178 CID_173322 | CID_173322 | |
| 0.011 | 0.436 | 0.081 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.081 0.05 CID_173322 | CID_173322 | |
| 0.039 | 0.472 | 0.181 | Streptokinase A inhibitor | 0.181 0.146 CID_173322 | CID_173322 | |
| 0.007 | 0.441 | 0.069 | Alcohol oxidase inhibitor | 0.069 0.029 CID_173322 | CID_173322 | |
| 0.043 | 0.485 | 0.224 | 12-Lipoxygenase inhibitor | 0.224 0.126 CID_173322 | CID_173322 | |
| 0.064 | 0.51 | 0.151 | Neurotensin receptor agonist | 0.151 0.098 CID_173322 | CID_173322 | |
| 0.02 | 0.479 | 0.078 | Keratolytic | 0.078 0.052 CID_173322 | CID_173322 | |
| 0.083 | 0.547 | 0.18 | Nitric-oxide synthase stimulant | 0.18 0.128 CID_173322 | CID_173322 | |
| 0.078 | 0.544 | 0.131 | Ca2+-transporting ATPase inhibitor | 0.131 0.113 CID_173322 | CID_173322 | |
| 0.048 | 0.519 | 0.199 | Transcription factor STAT inhibitor | 0.199 0.14 CID_173322 | CID_173322 | |
| 0.025 | 0.501 | 0.316 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.316 0.06 CID_173322 | CID_173322 | |
| 0.025 | 0.523 | 0.104 | Aldehyde dehydrogenase inhibitor | 0.104 0.091 CID_173322 | CID_173322 | |
| 0.012 | 0.511 | 0.098 | Urease inhibitor | 0.098 0.069 CID_173322 | CID_173322 | |
| 0.017 | 0.52 | 0.117 | Alkaline phosphatase inhibitor | 0.117 0.09 CID_173322 | CID_173322 | |
| 0.015 | 0.518 | 0.062 | Dihydroorotate oxidase inhibitor | 0.062 0.026 CID_173322 | CID_173322 | |
| 0.005 | 0.51 | 0.07 | NMDA receptor glycine site agonist | 0.07 0.036 CID_173322 | CID_173322 | |
| 0.003 | 0.509 | 0.041 | Fructose-1,6-bisphosphatase inhibitor | 0.041 0.037 CID_173322 | CID_173322 | |
| 0.031 | 0.538 | 0.221 | DNA synthesis inhibitor | 0.221 0.094 CID_173322 | CID_173322 | |
| 0.033 | 0.551 | 0.136 | GABA C receptor rho-2 antagonist | 0.136 0.094 CID_173322 | CID_173322 | |
| 0.034 | 0.555 | 0.205 | Calpain 2 inhibitor | 0.205 0.183 CID_173322 | CID_173322 | |
| 0.029 | 0.553 | 0.095 | D-Ala-D-Ala ligase inhibitor | 0.095 0.035 CID_173322 | CID_173322 | |
| 0.014 | 0.54 | 0.201 | Aryl hydrocarbon receptor agonist | 0.201 0.102 CID_173322 | CID_173322 | |
| 0.01 | 0.536 | 0.06 | NMDA receptor agonist | 0.06 0.047 CID_173322 | CID_173322 | |
| 0.034 | 0.579 | 0.149 | Phospholipase C inhibitor | 0.149 0.108 CID_173322 | CID_173322 | |
| 0.044 | 0.593 | 0.278 | Histamine release inhibitor | 0.278 0.136 CID_173322 | CID_173322 | |
| 0.025 | 0.575 | 0.201 | Succinate dehydrogenase inhibitor | 0.201 0.048 CID_173322 | CID_173322 | |
| 0.04 | 0.59 | 0.228 | Superoxide dismutase inhibitor | 0.228 0.091 CID_173322 | CID_173322 | |
| 0.004 | 0.564 | 0.091 | Dihydroorotate dehydrogenase inhibitor | 0.091 0.014 CID_173322 | CID_173322 | |
| 0.007 | 0.569 | 0.101 | Porphobilinogen synthase inhibitor | 0.101 0.035 CID_173322 | CID_173322 | |
| 0.006 | 0.575 | 0.055 | Dihydroorotase inhibitor | 0.055 0.02 CID_173322 | CID_173322 | |
| 0.02 | 0.59 | 0.091 | Carbonic anhydrase III inhibitor | 0.091 0.073 CID_173322 | CID_173322 | |
| 0.004 | 0.579 | 0.037 | Nicotinic acid receptor agonist | 0.037 0.024 CID_173322 | CID_173322 | |
| 0.015 | 0.595 | 0.095 | GABA C receptor rho-1 antagonist | 0.095 0.07 CID_173322 | CID_173322 | |
| 0.03 | 0.619 | 0.142 | Hexokinase inhibitor | 0.142 0.089 CID_173322 | CID_173322 | |
| 0.011 | 0.626 | 0.098 | GABA C receptor antagonist | 0.098 0.082 CID_173322 | CID_173322 | |
| 0.047 | 0.698 | 0.262 | 5 Hydroxytryptamine release inhibitor | 0.262 0.212 CID_173322 | CID_173322 | |
| 0.009 | 0.693 | 0.089 | Ferrochelatase inhibitor | 0.089 0.084 CID_173322 | CID_173322 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |